We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
+35.69%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$108M
AUM Growth
+$25.3M
Cap. Flow
+$4.17M
Cap. Flow %
3.87%
Top 10 Hldgs %
93.85%
Holding
31
New
6
Increased
10
Reduced
5
Closed
5

Top Buys

Rank Stock Value
1
ABDC
Alcentra Capital Corp
ABDC
+$5.23M
2
KALA icon
KALA BIO
KALA
+$1.01M
3
GSM icon
FerroAtlántica
GSM
+$317K
4
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$210K
5
CACC icon
Credit Acceptance
CACC
+$198K

Top Sells

Rank Stock Value
1
ICMB icon
Investcorp Credit Management BDC
ICMB
+$1.3M
2
JBGS
JBG SMITH
JBGS
+$778K
3
ACRS icon
Aclaris Therapeutics
ACRS
+$453K
4
INDP icon
Indaptus Therapeutics
INDP
+$318K
5
ARCC icon
Ares Capital
ARCC
+$273K

Sector Composition

Rank Sector Weight
1 Healthcare 69.43%
2 Financials 8.02%
3 Materials 0.26%
4 Technology 0.23%
5 Consumer Discretionary 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDG icon
26
TransDigm Group
TDG
$67.4B
$208K 0.19%
+458
New +$186K
ACRS icon
27
Aclaris Therapeutics
ACRS
$778M
– –
-61,264
Closed -$453K
ARCC icon
28
Ares Capital
ARCC
$13.6B
– –
-17,553
Closed -$273K
INDP icon
29
Indaptus Therapeutics
INDP
$328M
– –
-19
Closed -$318K
JBGS
30
JBG SMITH
JBGS
$847M
– –
-22,349
Closed -$778K
MRNS
31
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-15,361
Closed -$176K
1
2

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q1 2019 Portfolio in Review

As of Q1 2019, Caxton Corporation held 31 positions worth $108M, up 31% from $82.4M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Caxton Corporation deployed $4.17M of net new capital in Q1 2019, opening 6 new positions and adding to 10 existing holdings. Its largest new stake was FerroAtlántica: 139,226 shares worth $285K.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 69% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Investcorp Credit Management BDC, an estimated $1.3M trimmed.

  • Caxton Corporation's largest Q1 2019 buy was FerroAtlántica: 139,226 shares worth $285K.
  • Caxton Corporation added most to Alcentra Capital Corp in Q1 2019, an estimated $5.23M increase.
  • Caxton Corporation's biggest Q1 2019 reduction was Investcorp Credit Management BDC, cutting an estimated $1.3M.
  • Caxton Corporation fully exited JBG SMITH in Q1 2019, selling an estimated $778K.
  • Caxton Corporation's ten largest holdings make up 94% of its $108M portfolio in Q1 2019.
  • Caxton Corporation opened 6 new positions and closed 5 in Q1 2019.
  • Caxton Corporation's portfolio value rose 31% quarter-over-quarter to $108M.

Based on Caxton Corporation's 13F filing for Q1 2019, filed 14 May 2019.